You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (15) |
Back to Search
Evaluation of using a fixed-dose combination of glibenclamide and metformin compared to glibenclamide co-administered with metformin in type 2 diabetes outpatients
- In: Hospital Pharmacy - Posters
- At: Basel (Switzerland) (2008)
- Type: Poster
- Poster code: HPS-P-013
- By: YEN, Chih-ho (Department of Pharmacy, Taichung Veterans General Hospital, Taichung, Taiwan, Re, Taichung, Taiwan, Republic Of China, China Taiwan)
- Co-author(s): Chen, Hsiu-Mei (Department of Pharmacy, Taichung Veterans General Hospital, China Taiwan)
Liu, Ying-Mei (Department of Pharmacy, Taichung Veterans General Hospital, China Taiwan)
Cheng, Huang-Chi (Department of Pharmacy, Taichung Veterans General Hospital, China Taiwan)
Chen, Been-Yuan (Department of Pharmacy, Taichung Veterans General Hospital, China Taiwan) - Abstract:
Objectives: The study was conducted to evaluate the efficacy, side effects and economic benefits of using a fixed-dose glibenclamide/metformin tablets compared to glibenclamide co-administered with metformin in type 2 diabetes outpatients.
Methods: This retrospective study analyzed type 2 diabetes outpatients, who treated with a fixed-dose.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026